2022-08 | Quality by Design (QbD) application for the pharmaceutical development process | 김진기 |
2024-02-16 | A review on the nanotechnology-based approaches for managing sexually transmitted infections | 김진기 |
2018-11 | Role of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticles | 김진기 |
2016-06 | Selective inhibition of JAK2/STAT1 signaling and iNOS expression mediates the anti-inflammatory effects of coniferyl aldehyde | 김진기 |
2009-05 | Self-Assembling Peptide Amphiphile-Based Nanofiber Gel for Bioresponsive Cisplatin Delivery | 김진기 |
2005-01 | Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography | 김진기 |
2019-04 | Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model | 김진기 |
2020-06 | Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model | 김진기 |
2016-10 | Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers | 김진기 |
2009-08 | Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits | 김진기 |
2009-08 | Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits | 김진기 |
2017-06 | Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration | 김진기 |
2009-03 | Thermo-reversible flurbiprofen liquid suppository with HP-beta-CD as a solubility enhancer: improvement of rectal bioavailability | 김진기 |
2009-03 | Thermo-reversible flurbiprofen liquid suppository with HP-beta-CD as a solubility enhancer: improvement of rectal bioavailability | 김진기 |
2005-05 | The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer | 김진기 |
2009-10 | The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator | 김진기 |
2009-10 | The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator | 김진기 |